Independent Advisor Alliance Boosts Stake in CME Group Inc. (NASDAQ:CME)

Independent Advisor Alliance raised its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 23.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,827 shares of the financial services provider’s stock after buying an additional 1,692 shares during the period. Independent Advisor Alliance’s holdings in CME Group were worth $2,050,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of CME. Truvestments Capital LLC bought a new position in CME Group in the 3rd quarter valued at $26,000. SJS Investment Consulting Inc. boosted its stake in shares of CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 97 shares during the period. Dunhill Financial LLC grew its holdings in shares of CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 81 shares during the last quarter. Financial Life Planners purchased a new position in CME Group in the 4th quarter worth about $32,000. Finally, Fortitude Family Office LLC lifted its holdings in CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after buying an additional 83 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock opened at $259.84 on Friday. The firm has a market capitalization of $93.64 billion, a P/E ratio of 26.87, a PEG ratio of 6.76 and a beta of 0.53. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $263.65. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The company has a 50 day moving average price of $242.28 and a 200 day moving average price of $231.97.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group declared that its Board of Directors has authorized a share buyback plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s management believes its stock is undervalued.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.92%. This is a positive change from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s payout ratio is 51.71%.

Insider Activity at CME Group

In other news, COO Suzanne Sprague sold 1,500 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the transaction, the chief operating officer now directly owns 8,036 shares of the company’s stock, valued at $2,063,885.88. This represents a 15.73 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the completion of the sale, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. This represents a 12.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 17,076 shares of company stock worth $4,271,496 in the last three months. Company insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Barclays raised their target price on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Citigroup downgraded CME Group from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $255.00 to $250.00 in a report on Monday, January 6th. JPMorgan Chase & Co. upped their target price on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Oppenheimer raised their price target on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. Finally, Morgan Stanley upped their price objective on shares of CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 19th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $238.93.

Check Out Our Latest Research Report on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.